FDA Inspection 982641 - Wuhan Biocause Pharmaceutical Development Co., Ltd. - July 22, 2016

Record Details

This FDA Inspection record concerns Wuhan Biocause Pharmaceutical Development Co., Ltd., with an inspection on July 22, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Wuhan Biocause Pharmaceutical Development Co., Ltd.
Inspection Date: July 22, 2016
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 8bad144b-a3b7-4ef5-9617-13e620874c65